Aligning Diabetes Practice to High-Quality, Value-Based Care

Aligning Diabetes Practice to High-Quality, Value-Based Care

On-Demand Webcast

This webcast is based on live proceedings from the 2017 Patient-Centered Medical Home Congress.

Provided by North American Center for Continuing Medical Education, LLC, an HMP Company, and the National Committee for Quality Assurance




















Richard E. Pratley, MD
Samuel E. Crockett, MD Chair in Diabetes Research
Director, Florida Hospital Diabetes Institute
Senior Scientist, Translational Research Institute for Metabolism and Diabetes
Adjunct Professor,
Sanford Burnham Prebys Medical Discovery Institute
Orlando, Florida

Jeff Unger, MD, ABFM, FACE
Diplomate, American Board of Family Practice
Fellow, American Association of Clinical Endocrinologists
Director, Unger Concierge Primary Care Medical Group
Rancho Cucamonga, California

Intended Learners

This activity is designed for professionals devoted to transforming care through the medical home model of care, including primary care clinicians, allied health professionals, practice administrators, and quality managers.

Learning Objectives

After completion of this activity, participants should be able to:

  • Describe the clinical and economic impact of suboptimal management of type 2 diabetes on patients, families, and the US healthcare system
  • Outline the latest clinical trial data on available and emerging therapies for type 2 diabetes, including mechanisms of action, safety, efficacy, and risk/benefit profiles
  • Translate the latest clinical trial evidence, guideline recommendations, and 2017 ADA standards of medical care to individualized and comprehensive, patient-centered management
  • Assume the lead in implementing value-based care models such as PCMH or DRP to improve the quality and coordination of multidisciplinary, team-based diabetes care
Activity Overview

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form.

After successful completion of the post-test and evaluation form online at, participants may immediately print their documentation of credit.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring webcast.

Release Date: December 22, 2017
Expiration Date: December 22, 2018
Estimated time to complete: 1 hour

There is no fee associated with this activity.

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested for video programs. A PDF reader is required for print publications. Please direct technical questions to


In support of improving patient care, the National Committee for Quality Assurance (NCQA) is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE) and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for the healthcare team.


NCQA designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This educational activity is approved for 1.0 nursing education contact hour.


This activity is approved for 1.0 contact hour (.01 CEU) of continuing pharmacy education (UAN JA0004597-0000-18-014-H04-P).

This educational activity is a knowledge-based activity.

Nurse Reviewer: Johann Chanin, Senior Consultant, Steadman Group, Denver, CO

Planning Committee

The planning committee comprises  Johann Chanin, MSN, RN, PCMH CCE, Richard E. Pratley, MD, Jeff Unger, MD, ABFM, FACE; Vashon Coehins, Tina Coffron, and Bart Ecker, NCQA; and Kristin Ciszeski, Mary Johnson, Michael Kearney, Randy Robbin, and John Savage, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Pratley: Advisory Board/Consultant—Boehringer-Ingelheim, GlaxoSmithKline, Lilly, Merck, Novo Nordisk, Pfizer, Takeda; Research Support—Lexicon, Lilly, Merck, Novo Nordisk, Pfizer, Sanofi, Takeda
(all honoraria directed toward a non-profit which supports education and research)

Dr. Unger: Speakers Bureau/Advisory Board Member—Abbott Diabetes, Janssen, Novo Nordisk; Contracted research—Abbott Diabetes, GlaxoSmithKline, Janssen, Merck, Mylan, Novo Nordisk, Sanofi-Aventis

Ms. Chanin disclosed no relevant financial relationships with any commercial interests.

Ms. Coehins, Ms. Coffron, Mr. Ecker, Ms. Ciszeski, Ms. Johnson, Mr. Kearney, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty have disclosed no off label/unapproved uses of drugs and/or devices will be discussed in the presentations.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2017 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Grant Support

Supported by educational grants from Merck & Co., Inc. and Novo Nordisk